MIRAE ASSET TIGER KOSDAQ150BIOTECH ETF

An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.

261070 trades at 17,765 KRW today, its price has fallen −0.34% in the past 24 hours. Track more dynamics on 261070 price chart.

261070 net asset value is 17,335.00 today — it's fallen 10.32% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.

261070 assets under management is ‪48.20 B‬ KRW. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.

261070 price has fallen by −8.62% over the last month, and its yearly performance shows a 44.14% increase. See more dynamics on 261070 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −10.32% over the last month, have fallen by −10.32% over the last month, showed a 4.43% increase in three-month performance and has increased by 38.03% in a year.

261070 fund flows account for ‪16.91 B‬ KRW (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.

261070 expense ratio is 0.40%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.

No, 261070 isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.

In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, 261070 technical analysis shows the neutral rating and its 1-week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 261070 shows the buy signal. See more of 261070 technicals for a more comprehensive analysis.

Yes, 261070 pays dividends to its holders with the dividend yield of 0.23%.

261070 shares are issued by Mirae Asset Global Investments Co., Ltd.

261070 follows the KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

The fund started trading on Dec 14, 2016.